|
GB9917909D0
|
|
Cysteine protease inhibitors
|
|
GB9907683D0
|
|
Substituted azetidin-2-ones as cysteine protease inhibitors
|
|
US6133485A
|
|
Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl butan-2,3-diols
|
|
GB9806287D0
|
|
Monobactam enzyme inhibitors
|
|
US6153616A
|
|
Triazoles as therapeutic agents for fungal infections
|
|
US5959123A
|
|
3,4-Disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
|
|
US5994340A
|
|
Azetidinone derivatives as β-lactamase inhibitors
|
|
US5888998A
|
|
2-oxo-1-azetidine sulfonic acid derivatives as potent β-lactamase inhibitors
|
|
AU1730797A
|
|
3-substituted-4-oxa-1-azabicyclo{3,2,0}heptan-7-one as cysteine protease inhibitors
|
|
WO9706172A1
|
|
Novel penam sulfones as beta-lactamase inhibitors
|
|
WO9632408A1
|
|
Novel 4-substituted-3-peptidyl-azetidin-2-one derivatives useful as cysteine proteinase inhibitor
|
|
JPH08253459A
|
|
Improved economical method of producing 1,2,3-triazoles
|
|
AU2989395A
|
|
6beta -substituted penicillanic acids as beta -lactamase inhibitors
|
|
US5502068A
|
|
Cyclopropylpyrroloindole-oligopeptide anticancer agents
|
|
US5530134A
|
|
Synthesis of anabaseine, salts and derivatives thereof
|
|
WO9504732A1
|
|
Oligopeptide antiretroviral agents
|
|
US5478947A
|
|
Effective process for the production of 1,2,3-triazoles
|
|
US5446037A
|
|
2-[(substituted) methylene]cephalosporin sulfones as antiinflammatory, antidegenerative and antithrombin agents
|
|
US5439904A
|
|
2-spiro(2'-spirocycloalkyl)cyclopropyl cephalosporin sulfones as antiinflammatory and antigenerative agents
|
|
US5342846A
|
|
7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and 7-(substituted triazolyl pyrrolidin-1-yl) 4-oxoquinoline-3-carboxylic acid derivatives useful as antibacterial agents
|
